ASSERTIO THERAPEUTICS, INC. Deferred Tax Assets, Valuation Allowance
ASSERTIO THERAPEUTICS, INC. had Deferred Tax Assets, Valuation Allowance of $90.82 million as of 2019-12-31, per its 10-K filed 2020-03-10.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsValuationAllowance · last filed 2020-03-10
- 2019-12-31: Deferred Tax Assets, Valuation Allowance $90.82M.
- 2018-12-31: Deferred Tax Assets, Valuation Allowance $41.91M.
- 2017-12-31: Deferred Tax Assets, Valuation Allowance $54.22M.
- 2016-12-31: Deferred Tax Assets, Valuation Allowance $45.21M.
| Period end | Deferred Tax Assets, Valuation Allowance |
|---|---|
| 2019-12-31 | $90.82M 10-K · filed 2020-03-10 |
| 2018-12-31 | $41.91M 10-K · filed 2020-03-10 |
| 2017-12-31 | $54.22M 10-K · filed 2019-03-11 |
| 2016-12-31 | $45.21M 10-K · filed 2018-03-01 |
| 2015-12-31 | $574.00K 10-K · filed 2017-02-24 |
| 2014-12-31 | $4.31M 10-K · filed 2016-02-26 |
| 2013-12-31 | $2.67M 10-K · filed 2015-02-26 |
| 2012-12-31 | $42.50M 10-K · filed 2014-03-17 |
| 2011-12-31 | $34.70M 10-K · filed 2013-02-22 |